Eligible expenses in Stage 3 must meet the following criteria:
- They are unanticipated additional costs that would not have been incurred in the absence of the COVID-19 pandemic and cannot be funded by existing sources of funds
- They are direct costs associated with maintenance and ramp-up of research activities
- They are costs borne by research projects
Only direct costs of research that are extraordinary and incremental to those already covered by existing sources of funds and have been incurred between March 15 and November 15, 2020 are eligible for reimbursement, at up to 75%. Administrative costs, such as indirect costs, overhead or transaction costs are not eligible expenses of CRCEF. Costs of research personnel are not an eligible expense at this stage.
Extraordinary incremental costs are defined as unanticipated additional costs that would not normally have been incurred in the absence of the COVID-19 pandemic and cannot be funded by existing sources of funds.
The University must report on the use of the Stage 3 funds by November 16, 2020 or risk losing its allocation. In order to ensure reporting validation for the external deadline, ORIS requests that all eligible expenses be processed by November 10. Where this is not possible, please advise ORIS at time of application.
Costs incurred within the eligible period and associated with maintaining essential research-related activities during the pandemic that are exceptional and incremental to those already covered by existing sources of funds, funded at up to 75%. This includes:
- animal and specimen care through the crisis period;
- maintenance of equipment, software, cohorts, datasets, including warranties, licenses and service contracts;
- technological equipment for remote access to maintain assets; and
- safety equipment for personnel dedicated to maintenance.
Costs incurred within the eligible period and associated with full ramp-up of research activities, as physical distancing measures are eased and research activities can resume. Only costs that are exceptional and incremental to those already covered by existing sources of funds will be supported, at up to 75% of expenses. Eligible expenses include those incurred at the project level and associated with:
- re-organizing the research environment and activities;
- additional costs to bring the research back to its pre-pandemic level, including experiments or related to the restart of collections and datasets (e.g., population-based, environmental);
- user fees charged by shared platforms to researchers to restart research activities (e.g., animal- care facilities, digital labs);
- re-scheduling and restarting human and clinical trials;
- exceptional costs to access special facilities, shared platforms and resources, knowledge transfer meetings and workshops;
- restarting, reassembling and safety checks of equipment and facilities;
- reacquiring lost and donated laboratory and field supplies and equipment, reagents, perishable materials, laboratory animal and other living specimens; and
- personal protective equipment and related items for research personnel.
NOTE: Salaries of research personnel
Research personnel salaries incurred between August 30, 2020 and November 15, 2020 can be eligible for partial reimbursement up to 75% provided that they meet the Stage 3 eligibility criteria.
If you have any questions on the eligiblilty of an expense, please contact Penny Pickles (email@example.com) prior to application.
How to apply
Faculty members that have incurred eligible Stage 3 expenses are invited to submit an application. Please note the application deadline has changed from October 30, 2020 to November 17, 2020.
Applications will be reviwed by an internal adjudication committee. Funding decisions will be announced in mid-November.
Please consult the CRCEF program guidelines for a full list of FAQs.